https://neogap.se/2026-04-28T06:05:22+00:00https://neogap.se/for-investors/2025-02-13T13:39:38+00:00https://neogap.se/our-technology/2025-02-13T19:56:09+00:00https://neogap.se/career/2026-01-08T07:57:29+00:00https://neogap.se/contact/2025-02-06T16:39:22+00:00https://neogap.se/about-us/2026-04-28T06:04:32+00:00https://neogap.se/news/2026-04-28T05:57:04+00:00https://neogap.se/about-us/our-team/2025-08-25T06:37:13+00:00https://neogap.se/news/neogap-and-cellerys-enter-collaboration-phase-ii-study-multiple-sclerosis/2025-05-28T06:29:52+00:00https://neogap.se/news/neogap-expands-team-with-software-expert-to-drive-cancer-immunotherapy-innovation/2025-05-28T06:31:48+00:00https://neogap.se/news/neogap-enrols-first-patient-in-phase-i-clinical-trial-of-personalised-immunotherapy-for-colorectal-cancer/2025-05-28T06:30:39+00:00https://neogap.se/news/neogaps-patented-technology-behind-groundbreaking-ms-research/2025-05-28T06:41:22+00:00https://neogap.se/news/neogap-secures-eu-patent-for-innovative-personalised-immunotherapy-technology/2025-05-28T06:34:34+00:00https://neogap.se/news/neogap-acquires-tcer-oncology-ab-strengthening-its-position-in-personalised-immunotherapy/2025-05-28T06:28:49+00:00https://neogap.se/about-us/the-story-of-neogap/2025-02-13T20:06:24+00:00https://neogap.se/news/neogap-winner-of-business-swedens-catalyst-program/2025-05-28T06:39:59+00:00https://neogap.se/news/neogap-raises-sek-83-million-for-a-clinical-phase-i-ii-cancer-study/2025-05-28T06:33:28+00:00https://neogap.se/news/neogap-is-granted-australian-patent-for-innovative-method-of-ms-treatment-and-diagnosis/2025-05-28T06:32:45+00:00https://neogap.se/news/neogap-secures-eurostars-funding-to-develop-t-cell-activity-analysis/2025-05-28T06:35:26+00:00https://neogap.se/news/neogap-granted-chinese-patent-for-innovative-method-of-ms-treatment-and-diagnosis/2025-05-28T06:32:19+00:00https://neogap.se/events/2026-04-28T07:04:25+00:00https://neogap.se/news/neogap-therapeutics-partners-with-northx-biologics-to-advance-scalable-manufacturing-for-its-novel-cancer-cell-therapy/2025-05-28T06:37:03+00:00https://neogap.se/news/neogap-therapeutics-receives-emas-atmp-classification-for-its-personalised-cancer-cell-therapy/2025-05-28T06:37:35+00:00https://neogap.se/news/first-patients-treated-in-neogap-therapeutics-personalised-immunotherapy-trial/2025-05-28T06:27:45+00:00https://neogap.se/news/neogap-therapeutics-pior-technology-identifies-targets-for-personalised-liver-cancer-immunotherapies/2025-05-28T06:39:14+00:00https://neogap.se/news/neogap-therapeutics-awarded-scaleready-g-rex-grant-to-advance-personalised-cancer-immunotherapy/2025-05-28T06:36:10+00:00https://neogap.se/news/initial-data-from-neogap-therapeutics-personalised-immunotherapy-trial-supports-a-positive-safety-profile/2025-05-28T06:28:12+00:00https://neogap.se/news/neogap-therapeutics-selected-for-the-innovate-nordics-2025-acceleration-program/2025-05-28T06:38:26+00:00https://neogap.se/news/neogap-therapeutics-selected-for-eic-soft-landing-programme-in-boston/2025-05-28T06:38:01+00:00https://neogap.se/news/neogap-receives-approval-to-administer-full-dose-in-clinical-trial-streamlining-development-of-its-personalised-cell-therapy/2025-05-28T06:08:26+00:00https://neogap.se/news/neogap-to-present-at-neoantigen-summit-europe-2025/2025-08-26T10:52:13+00:00https://neogap.se/news/neogap-appoints-leading-international-cell-therapy-expert-to-its-board/2025-08-26T10:56:46+00:00https://neogap.se/about-us/gender-equality-and-diversity-plan/2025-09-11T08:30:50+00:00https://neogap.se/news/neogap-strengthens-global-ip-position-with-chinese-patent-for-t-cell-expansion-method/2025-10-01T07:25:51+00:00https://neogap.se/news/neogap-launches-collaboration-with-weill-cornell-medicine-through-vinnova-funded-project/2025-11-05T07:46:24+00:00https://neogap.se/news/neogaps-epitcer-technology-contributes-to-a-study-in-cell-advancing-the-understanding-of-multiple-sclerosis/2026-04-28T06:01:22+00:00https://neogap.se/news/neogap-secures-sek-87-million-to-advance-clinical-development-of-its-personalised-immunotherapy/2026-04-28T06:00:14+00:00https://neogap.se/news/neogap-selected-by-eic-for-bio-international-convention-2026/2026-04-28T05:50:58+00:00